Precision Biosciences DTIL
NASDAQ DTIL
$6.33 +0.07 (+1.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) EBT Margin (2018 - 2026)

Updated

Precision Biosciences (DTIL) posted EBT Margin of -77.39% for fiscal Q1 2026 (quarter ended Mar 31, 2026), up 72829.51 percentage points from -72906.90% a year earlier but down 115.20 percentage points from the prior quarter.

Analysis

Precision Biosciences (DTIL) EBT Margin (2018 - 2026) Analysis & Trends

For FY2025 (ended Dec 31, 2025), Precision Biosciences' EBT Margin came in at -143.97%, down 113.14 percentage points from FY2024.

  • Annual EBT Margin shows a five-year change of +304.89 percentage points (FY2020 to FY2025).
  • In prior fiscal years, Precision Biosciences' EBT Margin was -30.83% in FY2024 (+47.73 pp), -78.56% in FY2023 (+160.29 pp), -238.85% in FY2022 (-204.83 pp) and -34.02% in FY2021 (+414.84 pp).
  • Quarterly EBT Margin has run from a low of -153861.54% in fiscal Q3 2025 to a high of 50.96% in fiscal Q2 2024 over five years.
  • On a year-over-year basis, EBT Margin increased in three of the last eight quarters, with an average year-over-year change of -33865.54 percentage points.
  • The strongest year-over-year quarter for EBT Margin in the past five years was fiscal Q1 2026, with a gain of 72829.51 percentage points; the weakest was fiscal Q3 2025, with a drop of 150429.59 percentage points.
  • According to Business Quant data, EBT Margin for the three prior fiscal quarters was 37.81% (Q4 2025), -153861.54% (Q3 2025) and -117327.78% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 26.66%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 25.18%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -4.11%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 29.63%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.19%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 27.53%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -131.41%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 41.75%
10 Precision Biosciences 165.47 Mn -183.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -77.39%
Dec 31, 2025 37.81%
Sep 30, 2025 -153,861.54%
Jun 30, 2025 -117,327.78%
Mar 31, 2025 -72,906.90%
Dec 31, 2024 -3,721.63%
Sep 30, 2024 -3,431.94%
Jun 30, 2024 50.96%
Mar 31, 2024 -17.62%
Dec 31, 2023 -193.83%
Sep 30, 2023 -84.37%
Jun 30, 2023 -8.77%
Mar 31, 2023 -134.77%
Dec 31, 2022 -100.57%
Sep 30, 2022 -188.90%
Jun 30, 2022 -773.30%
Mar 31, 2022 -820.17%
Dec 31, 2021 -484.52%
Sep 30, 2021 -48.07%
Jun 30, 2021 31.47%
API Access

Precision Biosciences EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=DTIL&period=max&api_key=YOUR_API_KEY